Brad Miles founded BMC Communications Group LLC, in 1996 as a public relations agency focused exclusively on the needs of emerging and established health-care companies. Brad has more than 15 years of experience in the health care public relations agency setting, where he developed communications strategies for biotechnology and pharmaceutical companies in both corporate and product practice areas. Prior to founding BMC, Brad was Senior Vice President of Ted Klein & Company (1990 to 1996), a New York-based pharmaceutical public relations agency. At Ted Klein & Company, he directed new product introductions of Bristol-Myers Squibb’s BuSpar and Stadol NS, and worked on corporate strategies around the cancer drug blockbuster, Taxol. Brad also developed product communications for brands Nicorette and Seldane. At BMC he has provided strategic guidance to more than 50 private and publicly traded biotechnology companies, advising management on strategies around product pipeline progress through FDA approvals and launch. He built BMC into a leading, independent public relations firm serving biotechnology companies. Brad began his career in Washington, D.C., as a public affairs specialist at the U.S. Department of Commerce, and then as Director of Public Relations for a leading telecommunications trade group. He lives in lower Manhattan with his wife and son.